Fulgent Genetics, Inc. provided earning guidance for second quarter of 2022. For the second quarter of 2022, the company expects Total Revenue of approximately $125 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.74 USD | -1.67% | -2.03% | -24.80% |
May. 03 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
May. 03 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.80% | 651M | |
-22.04% | 8.54B | |
+68.22% | 4.32B | |
-1.43% | 2.53B | |
-9.63% | 2.46B | |
-38.23% | 2.48B | |
-7.85% | 1.9B | |
-17.74% | 1.59B | |
-39.48% | 1.23B | |
+9.68% | 1.13B |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Fulgent Genetics, Inc. Provides Earning Guidance for Second Quarter of 2022